Terms: = Gastric cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
43 results:
1. Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer.
Liu J; Zhu T; Zhao R; Ren W; Zhao F; Liu J
Gastric Cancer; 2024 May; 27(3):495-505. PubMed ID: 38386239
[TBL] [Abstract] [Full Text] [Related]
2. Profiling Kinase Activities for Precision Oncology in Diffuse gastric cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract] [Full Text] [Related]
3. Gancao Xiexin Decoction inhibits gastric carcinoma proliferation and migration by regulating the JAK2/STAT3 signalling pathway.
Yang Y; Yuan L; Meng F; Lu D; Che M; Zhou X; Chen G; Ning N; Nan Y
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117241. PubMed ID: 37777026
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
5. hsp90aB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian cancer.
Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
[TBL] [Abstract] [Full Text] [Related]
6. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Naito Y; Nishida T; Doi T
Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
[TBL] [Abstract] [Full Text] [Related]
7. Role of Ganetespib, an hsp90 Inhibitor, in cancer Therapy: From Molecular Mechanisms to Clinical Practice.
Youssef ME; Cavalu S; Hasan AM; Yahya G; Abd-Eldayem MA; Saber S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902446
[TBL] [Abstract] [Full Text] [Related]
8. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
[TBL] [Abstract] [Full Text] [Related]
9. Isoquercitrin Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in gastric cancer Cells.
Liu J; Ren L; Wang H; Li Z
Biochem Genet; 2023 Jun; 61(3):1128-1142. PubMed ID: 36480095
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive proteomic and phosphoproteomic reveal that Microcystin-LR contributed to the malignant progression of gastric cancer by estrogenic potency.
Yang P; Zhang P; Deng Y; Liao Y; Guo X; Sun M; Yin L; Liu R
Environ Pollut; 2023 Jan; 317():120744. PubMed ID: 36436660
[TBL] [Abstract] [Full Text] [Related]
11. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract] [Full Text] [Related]
12. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Analysis of Epigenetic Associated Genes with Differential Gene Expression and Prognosis in gastric cancer.
An S; Li X; Li B; Li Y
Comb Chem High Throughput Screen; 2023; 26(3):527-538. PubMed ID: 35570548
[TBL] [Abstract] [Full Text] [Related]
14. The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives.
Bailly C
Biochem Pharmacol; 2022 Mar; 197():114895. PubMed ID: 34968491
[TBL] [Abstract] [Full Text] [Related]
15. TAS-116 (Pimitespib), an Oral hsp90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704).
Kawazoe A; Itahashi K; Yamamoto N; Kotani D; Kuboki Y; Taniguchi H; Harano K; Naito Y; Suzuki M; Fukutani M; Higuchi T; Ikeno T; Wakabayashi M; Sato A; Koyama S; Nishikawa H; Shitara K
Clin Cancer Res; 2021 Dec; 27(24):6709-6715. PubMed ID: 34593531
[TBL] [Abstract] [Full Text] [Related]
16. Ailanthus Altissima-derived Ailanthone enhances gastric cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression.
Wang CM; Li HF; Wang XK; Li WG; Su Q; Xiao X; Hao TF; Chen W; Zhang YW; Zhang HY; Wu W; Hu ZR; Zhao GY; Huo MY; He YL; Zhang CH
Int J Biol Sci; 2021; 17(11):2811-2825. PubMed ID: 34345209
[TBL] [Abstract] [Full Text] [Related]
17. Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology.
Lu X; Zheng Y; Wen F; Huang W; Chen X; Ruan S; Gu S; Hu Y; Teng Y; Shu P
Sci Rep; 2021 Jan; 11(1):1905. PubMed ID: 33479376
[TBL] [Abstract] [Full Text] [Related]
18. A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Goyal L; Chaudhary SP; Kwak EL; Abrams TA; Carpenter AN; Wolpin BM; Wadlow RC; Allen JN; Heist R; McCleary NJ; Chan JA; Goessling W; Schrag D; Ng K; Enzinger PC; Ryan DP; Clark JW
Invest New Drugs; 2020 Oct; 38(5):1533-1539. PubMed ID: 31898183
[TBL] [Abstract] [Full Text] [Related]
19. Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating hsp90 function.
Xiong J; Wang S; Chen T; Shu X; Mo X; Chang G; Chen JJ; Li C; Luo H; Lee JD
Int J Biol Sci; 2019; 15(2):312-324. PubMed ID: 30745823
[TBL] [Abstract] [Full Text] [Related]
20. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
[TBL] [Abstract] [Full Text] [Related]
[Next]
